Marit Valla
Marit Valla
Associate professor in pathology
Department of Clinical and Molecular Medicine Faculty of Medicine and Health SciencesBackground and activities
- Associate professor in pathology at IKOM, NTNU
- Consultant pathologist at St. Olavs Hospital, Trondheim University hospital
- Research: Artificial intelligence in breast cancer, molecular pathology in breast cancer, gynaecological pathology
- Supervision of PhD candidates and medical students
- Leader of the teaching unit Anatomy, Pathology and Forensic medicine
- Teaching histology and pathology
Qualifications and fields of interest
- Pathologist with special interest in breast and gynaecological pathology
- Use of artificial intelligence in pathology, molecular pathology
- Multidisciplinary work
- Member of the Research group and board member of the Norwegian Pathology Society
- Member of the Nordic Network of Gynecologic Pathologists
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
Journal publications
- (2021) FGFR1 copy number in breast cancer: associations with proliferation, histopathological grade and molecular subtypes. Journal of Clinical Pathology.
- (2021) ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes. Breast Cancer Research and Treatment.
- (2021) FastPathology: An open-source platform for deep learning-based research and decision support in digital pathology. IEEE Access. vol. 9.
- (2021) The association of women’s birth size with risk of molecular breast cancer subtypes: a cohort study. BMC Cancer. vol. 21 (1).
- (2021) DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis. Breast Cancer Research and Treatment. vol. 187 (1).
- (2020) MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes. Breast Cancer Research and Treatment. vol. 180.
- (2018) The prognostic value of androgen receptors in breast cancer subtypes. Breast Cancer Research and Treatment.
- (2018) Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs. Neoplasia. vol. 20 (4).
- (2018) Characterization of FGD5 expression in primary breast cancers and lymph node metastases. Journal of Histochemistry and Cytochemistry.
- (2017) Basal markers and prognosis in luminal breast cancer. Breast Cancer Research and Treatment. vol. 163 (2).
- (2017) A selective biomarker panel increases reproducibility and accuracy in endometrial biopsy diagnosis. International Journal of Gynecological Pathology. vol. 36 (4).
- (2017) FGD5 amplification in breast cancer patients is associated with tumor proliferation and a poorer prognosis. Breast Cancer Research and Treatment. vol. 162 (2).
- (2016) Colposcopy and additive diagnostic value of biopsies from colposcopy-negative areas to detect cervical dysplasia. Acta Obstetricia et Gynecologica Scandinavica. vol. 95 (11).
- (2016) Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm. Gynecologic Oncology. vol. 143 (3).
- (2016) Molecular subtypes of breast cancer: Long-term incidence trends and prognostic differences. Cancer Epidemiology, Biomarkers and Prevention. vol. 25 (12).
- (2012) Implementation of step sectioning in the examination of sentinel lymph nodes to improve the detection of micrometastases in breast cancer patients. APMIS - Journal of Pathologiy, Microbiology and Immunology. vol. 120 (7).
- (2005) Omorganisering innen kirurgi har følger for nyremedisinsk virksomhet. Tidsskrift for Den norske legeforening. vol. 125.